Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Macerich Company (The) Common Stock (MAC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs Macerich Company (The) Common Stock — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $106.9 (market cap $8.87B), while Macerich Company (The) Common Stock trades at $22.18 (market cap $6.39B). The key difference: Kymera Therapeutics Inc. Common Stock is the larger of the two by market cap, and Macerich Company (The) Common Stock pays a 3.02% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Macerich Company (The) Common Stock for 0 Days on average.
| KYMR | MAC | |
|---|---|---|
Market Cap | $8.87B | $6.39B |
Volume | 779,107 | 2,684,151 |
Sector | Health | Real Estate |
52-Week High | $127.31 | $26.51 |
52-Week Low | $55.80 | $16.20 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $8.26B | $11.07B |
Dividend Yield | — | 3.02% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About Macerich Company (The) Common Stock
The Macerich Company is a real estate investment trust that owns, operates, and redevelops shopping centers concentrated in California, the Pacific Northwest, and other major US markets.
Read more on MAC →
